Mapping the heparin-binding sites on type I collagen monomers and fibrils.
about
Candidate cell and matrix interaction domains on the collagen fibril, the predominant protein of vertebratesAlways cleave up your mess: targeting collagen degradation to treat tissue fibrosisThe signal peptide of Staphylococcus aureus panton valentine leukocidin LukS component mediates increased adhesion to heparan sulfatesHeparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7)Two different heparin-binding domains in the triple-helical domain of ColQ, the collagen tail subunit of synaptic acetylcholinesteraseMolecular dynamics simulations on networks of heparin and collagen.Fell-Muir Lecture: Heparan sulphate and the art of cell regulation: a polymer chain conducts the protein orchestra.The influence of glycosaminoglycans and crosslinking agents on the phenotype of hepatocytes cultured on collagen gels.Pathway for polyarginine entry into mammalian cellsConsortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans.Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen.Chlorination of pyridinium compounds. Possible role of hypochlorite, N-chloramines, and chlorine in the oxidation of pyridinoline cross-links of articular cartilage collagen type II during acute inflammation.Cell surface heparan sulfate proteoglycans control adhesion and invasion of breast carcinoma cells.The collagen triple-helix: correlation of conformation with biological activities.Preferential sites for intramolecular glucosepane cross-link formation in type I collagen: A thermodynamic study.Defining the domains of type I collagen involved in heparin- binding and endothelial tube formation.Intra-molecular lysine-arginine derived advanced glycation end-product cross-linking in Type I collagen: A molecular dynamics simulation study.Collagen-Based Substrates with Tunable Strength for Soft Tissue Engineering.Perlecan domain I promotes fibroblast growth factor 2 delivery in collagen I fibril scaffolds.Recognition of dextran-superparamagnetic iron oxide nanoparticle conjugates (Feridex) via macrophage scavenger receptor charged domains.Heparin sensitive and resistant vascular smooth muscle cells: biology and role in restenosis.Mutation in the heparan sulfate biosynthesis enzyme EXT1 influences growth factor signaling and fibroblast interactions with the extracellular matrix.Non-enzymatic glycation of type I collagen diminishes collagen-proteoglycan binding and weakens cell adhesionInteraction of the collagen-like tail of asymmetric acetylcholinesterase with heparin depends on triple-helical conformation, sequence and stability.Collagen-Gold Nanoparticle Conjugates for Versatile BiosensingOvarian carcinoma cells synthesize both chondroitin sulfate and heparan sulfate cell surface proteoglycans that mediate cell adhesion to interstitial matrix.Revealing Accessibility of Cryptic Protein Binding Sites within the Functional Collagen Fibril.Structure analysis of collagen fibril at atomic-level resolution and its implications for intra-fibrillar transport in bone biomineralization.A polyelectrolyte multilayer platform for investigating growth factor delivery modes in human liver cultures.Structural requirements for heparin/heparan sulfate binding to type V collagen.Extracellular matrix-inspired assembly of glycosaminoglycan–collagen fibers
P2860
Q24656537-2B29919D-D43B-4AA7-AC59-E0D1393F5A3EQ26827393-9AC5DFCF-9C1D-4BCB-8BE7-A0867038F567Q28475214-9F9EEC8C-1BD5-4465-97D8-B5EBF3C5CCD2Q28564762-D21BFE9E-2359-4E40-AEF5-3F93B6EA453EQ28568196-A160EB1B-8ACB-4D21-8CD5-91FD9F856EE3Q30399511-36351480-2389-4739-861E-C8F10482D446Q30568524-F0CCD46A-3E46-4F75-99EE-97CC5BE79CEBQ30916437-BB095870-BBAA-4970-ABE8-D267A7CFB386Q33644922-4DA7A898-6EF0-4C30-A4B6-EE4C22D711D9Q34088135-51BD30C7-AA36-4CFF-906C-5D609BC59C35Q34101398-31B49FCB-EBA7-49DA-BFE2-EB7D05E33369Q34139254-B1D30D1F-8681-4A99-AECA-6D283ADB900FQ35078198-3184730C-7486-4A2D-9B32-0065D23E0350Q35989153-E1169A09-9452-4404-BFBC-ACD816E20717Q36318930-E0577E77-43C4-4427-BC6A-2AD613312AE6Q36483511-D475D200-E2B6-485B-BDC5-CF948F3318DCQ37347016-FEFED9DA-739D-4B0D-BFA4-357FDFD69D8DQ37379438-08662625-A8F4-4478-871E-48B63DB5BFA7Q39078431-5A2FF283-B040-49B0-9A86-E072D8385191Q39627497-599769A7-DD28-4A12-9CF5-5507076F4E9CQ41030320-6248E4C3-98BB-476C-98EB-55F9A13F3553Q41808585-A679BF57-72A8-4D2F-A47A-11C8B0D28DD5Q41896828-A4B4C069-864A-4C20-9A01-039C233D228EQ41993170-21A42AAD-BF6B-40D2-8AD8-DE81F3F222DEQ42318611-FBB7B597-EC76-480C-8B63-86AAF5397A4FQ43748131-AC43C03B-8CD4-4ABC-8491-999B94D8EB05Q47112384-0DF127DC-38C8-42A8-9805-F82514E3A1D1Q47233012-A16C27DD-E1DA-4120-9718-7BBF16A9674AQ47346458-5B63F566-D1B6-4B57-85BF-2B806504916FQ51806250-81E91F8D-8B02-49AB-88D9-6B8ECF522E62Q57170648-87226FE4-AAAC-4B8C-A620-6CDE94D15EE5
P2860
Mapping the heparin-binding sites on type I collagen monomers and fibrils.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Mapping the heparin-binding sites on type I collagen monomers and fibrils.
@ast
Mapping the heparin-binding sites on type I collagen monomers and fibrils.
@en
type
label
Mapping the heparin-binding sites on type I collagen monomers and fibrils.
@ast
Mapping the heparin-binding sites on type I collagen monomers and fibrils.
@en
prefLabel
Mapping the heparin-binding sites on type I collagen monomers and fibrils.
@ast
Mapping the heparin-binding sites on type I collagen monomers and fibrils.
@en
P2093
P2860
P356
P1476
Mapping the heparin-binding sites on type I collagen monomers and fibrils.
@en
P2093
A D Lander
H S Slayter
J D San Antonio
M J Karnovsky
P2860
P304
P356
10.1083/JCB.125.5.1179
P407
P577
1994-06-01T00:00:00Z